Logo der Universität Basel

Research Database / FORSCHUNGSDATENBANK 
PRINTDOC
 
Publication 4514954 | Verified
 

Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Tofacitinib for the Treatment of Pyoderma Gangrenosum
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4514954
Author(s) Kochar, Bharati; Herfarth, Neel; Mamie, Céline; Navarini, Alexander A.; Scharl, Michael; Herfarth, Hans H.
Author(s) at UniBasel Navarini, Alexander
Year 2019
Title Tofacitinib for the Treatment of Pyoderma Gangrenosum
Journal Clinical gastroenterology and hepatology
Volume 17
Number 5
Pages / Article-Number 991-993
Abstract Pyoderma gangrenosum (PG) is a difficult-to-treat inflammatory skin condition that affects inflammatory bowel disease (IBD) patients. There is no standardized approach for PG treatment.; 1; We report the results of 3 patients with Crohn's disease (CD) and refractory PG who had failed several therapies with biologics and were started on tofacitinib for severe inflammatory arthritis with resolution of their PG.
Publisher Elsevier
ISSN/ISBN 1542-3565
edoc-URL https://edoc.unibas.ch/72191/
Full Text on edoc No
Digital Object Identifier DOI 10.1016/j.cgh.2018.10.047
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/30404036
ISI-Number WOS:000461795700034
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.379 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
06/05/2024